Reflexology for Chronic Constipation
Reflexology for Patients Suffering From Chronic Constipation- a Phase II B, Single Armed, Open Label Study.
1 other identifier
interventional
40
1 country
1
Brief Summary
The purpose of this study is to examine if the use of reflexology can alleviate chronic constipation. The trial will last 26 week per patient, 2 week of screening period, 12 weeks of treatment and 12 weeks of follow up. Included in the study will be 40 men and women, 18 years of age or older, which are able to comply with the study guidelines; Fewer than three spontaneous bowel movement per week; and one or more of the following symptoms/signs during more than 25% of bowel movements for at least 12 weeks within the preceding 12 months: (1) straining, lumpy or (2) hard stools, and (3) a sensation of incomplete evacuation. Exclusion criteria are: Loose or watery stool in the absence of laxative use for more than 25% of bowel movements during the 12 weeks preceding the trials; Mushy stool defined as a score of 6 on the Bristol Stool Form Scale for any SBM during the baseline period; Rome III criteria for the irritable bowel syndrome; History of pelvic-floor dysfunction; Neurological pathologies; Psychiatric conditions; Chronic use of medication with a gastro intestinal-activity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Jul 2012
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 6, 2012
CompletedFirst Posted
Study publicly available on registry
May 15, 2012
CompletedStudy Start
First participant enrolled
July 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2013
CompletedJanuary 15, 2013
July 1, 2012
9 months
May 6, 2012
January 14, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in complete spontaneous bowel movements (CSBM)/week from baseline to 24 weeks
Will be assessed daily during the 24 weeks of the study
24 weeks
Increase of at least one CSBM per week from baseline for 9 or more weeks during the 24-week treatment period
Will be assessed weekly during the 24 weeks of the study
24 weeks
Secondary Outcomes (10)
Stool frequency/Week (CSBMs and spontaneous bowel movements (SBMs)
24 weeks
Stool consistency/week using the 7- point Bristol Stool Form Scale, during the 24 weeks of the study period
24 weeks
Severity of straining using a 5-point ordinal scale (1 indicates not at all; 5 an extreme amount).
24 weeks
Abdominal discomfort, using a 5-point ordinal scale (1 indicates not at all; 5 an extreme amount)
24 weeks
Severity of bloating, using a 5-point ordinal scale (1 indicates not at all; 5 an extreme amount)
24 weeks
- +5 more secondary outcomes
Study Arms (1)
Reflexology
EXPERIMENTALreflexology treatment, x2-3/week for 12 weeks
Interventions
Reflexology is a therapy whereby diagnosis and treatment are done on the patient's feet. According to reflexology, our feet are a micro-cosmos of our bodies and contain all the body's systems and internal organs. The treatment is palpation and massage of specific reflex points that respond to the body organs. This massage or palpitation of reflex points improves the physical function of the corresponding organ or system
Eligibility Criteria
You may qualify if:
- Age of 18-55 years
- Fewer than three SBMs per week (occurring without the use of a laxative, enema, or suppository within the preceding 24 hours)
- One or more of the following symptoms/signs during more than 25% of bowel movements for at least 12 weeks within the preceding 12 months:(1)straining, lumpy or (2) hard stools, and (3)a sensation of incomplete evacuation Six or fewer SBMs/week and fewer than three complete CSBMs/week during the 14-day baseline period.
- Ability to comply with the study guidelines
You may not qualify if:
- Loose or watery stool in the absence of laxative use for more than 25% of bowel movements during the 12 weeks preceding the trials.
- Mushy stool defined as a score of 6 on the Bristol Stool Form Scale for any SBM during the baseline period.
- Rome III criteria for the irritable bowel syndrome.
- History of pelvic-floor dysfunction.
- Neurological pathologies
- Psychiatric conditions
- Chronic use of medication with a GI-activity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Center for Integrative Complementary Medicine, Shaare Zedek Medical Center
Jerusalem, Israel
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Menachem Oberbaum, MD
Menachem Oberbaum, MD, Phone:+972-2-6666395, Email: oberbaum@szmc.org.il
- PRINCIPAL INVESTIGATOR
Joseph Lysy
Joseph Lysy,Phone: +972-2-6666116 Email: lysyj@szmc.org.il
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 6, 2012
First Posted
May 15, 2012
Study Start
July 1, 2012
Primary Completion
April 1, 2013
Study Completion
April 1, 2013
Last Updated
January 15, 2013
Record last verified: 2012-07